SNPHY - Santen Pharmaceutical Co. Ltd. reports FY results May, 12 2021 05:37 AM Santen Pharmaceutical Co. Ltd. ADR Santen Pharmaceutical Co., Ltd. (SNPHY): FY Non-GAAP EPS of ¥93.87; GAAP EPS of ¥17.06.Revenue of ¥249.6B (+3.3% Y/Y)Press Release For further details see: Santen Pharmaceutical Co., Ltd. reports FY results